technolog
morpholog
assess
count
blood
cell
advanc
recent
decad
particularli
white
cell
lineag
concomit
benefit
relat
diagnosi
prognosi
manag
inflammatori
malign
condit
full
rang
measur
avail
modern
autom
laboratori
analys
howev
depend
servic
provid
central
laboratori
certain
limit
potenti
clinic
oper
econom
implic
issu
could
aris
set
rapid
decis
make
requir
eg
emerg
depart
primari
care
paramed
rural
servic
outofhour
doctor
servic
home
well
middl
lowincom
countri
one
major
technolog
advanc
recognit
quantif
differenti
white
count
initi
threepart
differenti
count
expand
fivepart
differenti
count
differenti
granulocyt
count
neutrophil
basophil
eosinophil
count
viral
bacteri
infect
arguabl
common
caus
acquir
neutropenia
margin
neutrophil
destruct
circul
antibodi
neutrophil
level
may
also
decreas
due
congenit
haematolog
malign
result
radiotherapi
use
cytotox
chemotherapi
drug
extrem
reduct
neutrophil
count
lead
seriou
complic
febril
neutropenia
fever
neutrophil
count
increas
risk
sepsisassoci
mortal
necessit
urgent
clinic
assess
risk
patient
thu
chemotherapi
patient
given
immedi
empir
antibiot
upon
suspicion
infect
patient
access
rapid
differenti
white
count
vital
delay
administr
broadspectrum
intraven
antibiot
associ
increas
mortal
risk
overtreat
unnecessari
antibiot
opportun
cost
access
absolut
neutrophil
count
anc
difficult
earli
phase
develop
neutropenia
patient
chemotherapi
patient
tend
home
healthcar
profession
requir
obtain
venou
sampl
frequent
access
vein
need
preserv
deliveri
chemotherapi
often
alreadi
compromis
vesic
irrit
cytotox
drug
thu
routin
practic
monitor
neutrophil
count
chemotherapi
cycl
unless
patient
report
symptom
suggest
develop
sever
neutropenia
complic
infect
studi
compar
diagnost
perform
granulocyt
neutrophil
count
patient
receiv
chemotherapi
aim
studi
determin
threshold
total
granulocyt
repres
neutrophil
count
signal
chang
patient
manag
ii
determin
total
granulocyt
could
use
meaning
indic
neutrophil
count
neutropen
rang
cancer
patient
receiv
chemotherapi
studi
first
step
determin
whether
valid
consid
use
granulocyt
count
monitor
patient
receiv
chemotherapi
analysi
conduct
pseudonymis
retrospect
databas
contain
peripher
venou
blood
sampl
result
januari
septemb
patient
receiv
chemotherapi
treatment
leed
cancer
centr
leed
teach
hospit
trust
ltht
ltht
result
server
receiv
blood
test
result
patholog
laboratori
display
electron
patient
record
system
patient
pathway
manag
ppm
pseudonymis
extract
taken
insert
research
databas
identifi
data
contain
within
dataset
research
sanction
inform
govern
procedur
ltht
data
extract
pseudonymis
procedur
agre
caldicott
guardian
formal
approv
nation
research
ethic
committe
nh
grampian
id
patient
exclud
base
chemotherapi
treatment
demograph
inform
diagnosi
time
treatment
blood
count
measur
edta
venou
whole
blood
sampl
obtain
purpos
routin
clinic
care
taken
time
relat
chemotherapi
deliveri
sampl
submit
full
blood
count
analysi
includ
fivepart
differenti
siemen
advia
analys
siemen
healthcar
diagnost
erlangen
germani
august
subsequ
siemen
advia
analys
instrument
employ
method
principl
instrument
subject
multipl
qualiti
control
qc
check
day
accord
standard
laboratori
protocol
laboratori
particip
unit
kingdom
nation
extern
qualiti
assess
servic
ukneqa
extern
qualiti
assur
scheme
data
interest
includ
eosinophil
basophil
neutrophil
count
sum
three
paramet
taken
granulocyt
count
calcul
microsoft
sql
server
lymphocyt
monocyt
result
also
extract
analysi
withinday
time
inform
avail
patient
one
blood
test
given
day
data
day
exclud
avoid
ambigu
result
taken
true
valu
day
r
program
languag
packag
use
conduct
statist
analysi
produc
figur
pearson
productmo
correl
use
measur
strength
linear
associ
complet
granulocyt
count
compon
eosinophil
basophil
neutrophil
p
consid
signific
correct
differ
scale
raw
count
data
log
transform
standard
ln
x
mean
ln
x
standard
deviat
ln
x
passingbablok
regress
analysi
conduct
use
mcr
packag
r
perform
separ
subset
individu
neutrophil
count
classifi
normal
grade
neutropenia
cellsl
grade
neutropenia
cellsl
use
grade
criteria
defin
common
terminolog
criteria
advers
event
limit
memori
requir
comput
overhead
regress
analysi
random
subset
result
subset
blandaltman
plot
construct
order
assess
relat
neutrophil
total
granulocyt
count
differ
measur
plot
averag
two
measur
good
concord
conclud
enough
point
fall
within
narrow
limit
agreement
confid
one
method
could
use
place
anoth
ie
mean
differ
close
zero
least
differ
exceed
standard
deviat
sd
data
divid
use
random
split
sampl
deriv
valid
dataset
multinomi
logist
regress
use
vgam
packag
employ
deriv
data
deriv
equival
granulocyt
count
rang
classifi
neutrophil
result
neutropenia
grade
defin
model
perform
measur
report
valid
dataset
neutrophil
classif
section
grade
also
assess
abil
identifi
neutrophil
result
final
threshold
adjust
use
optimis
valu
specif
object
use
optim
cutpoint
packag
test
result
one
neutrophil
eosinophil
basophil
monocyt
lymphocyt
count
result
per
patient
per
day
distribut
count
result
complet
granulocyt
differenti
count
assess
fig
total
number
result
within
refer
rang
neutrophil
cellsl
eosinophil
cellsl
basophil
cellsl
total
result
fell
within
refer
rang
eosinophil
basophil
neutrophil
result
result
within
upper
limit
normal
three
granulocyt
compon
consid
granulocyt
diseas
state
result
neutropenia
cellsl
neutrophilia
cellsl
eosinopenia
cellsl
eosinophilia
cellsl
basopenia
cellsl
basophilia
cellsl
acknowledg
neutrophil
largest
compon
granulocyt
howev
extent
relationship
differenti
investig
view
predict
neutrophil
count
correl
coeffici
compar
neutrophil
count
found
granulocyt
eosinophil
basophil
eosinophil
plu
basophil
lessen
effect
skew
differ
scale
analysi
also
conduct
use
standardis
natur
logarithm
transform
valu
although
correl
improv
upon
transform
overal
remain
weak
eosinophil
basophil
granulocyt
eosinophil
basophil
passingbablok
regress
granulocyt
count
neutrophil
count
perform
two
group
accord
neutrophil
result
normal
grade
neutropenia
neutrophil
cellsl
n
grade
neutropenia
neutrophil
cellsl
n
fig
illustr
result
data
pair
lie
necessarili
ident
line
fact
highli
concentr
around
regress
line
spread
outlier
regress
line
slope
intercept
confid
interv
summar
tabl
previous
count
split
result
fig
show
result
granulocyt
count
exceed
neutrophil
count
cellsl
upper
limit
agreement
word
sum
eosinophil
basophil
count
exceed
cellsl
investig
result
reveal
result
granulocyt
count
exceed
neutrophil
count
cellsl
fig
analysi
individu
neutropenia
grade
reveal
grade
result
differ
less
cellsl
mean
grade
result
cellsl
mean
grade
result
cellsl
mean
grade
result
cellsl
mean
agreement
analysi
found
rel
small
mean
differ
neutrophil
result
rang
therefor
abil
correctli
classifi
neutropenia
grade
use
equival
granulocyt
count
rang
investig
complet
dataset
randomli
split
deriv
n
valid
n
subset
multinomi
logist
regress
classifi
train
test
respect
supplement
data
fig
equival
granulocyt
rang
deriv
classifi
neutrophil
determin
grade
tabl
achiev
accuraci
classif
result
within
refer
rang
use
granulocyt
count
cellsl
correct
time
incorrectli
includ
grade
neutropenia
result
case
equival
grade
count
cellsl
correct
predict
chanc
misclassifi
grade
neutropenia
result
worst
perform
posit
predict
valu
ppv
occur
identifi
grade
neutropenia
chanc
identifi
grade
neutropen
patient
display
grade
neutropenia
identif
grade
neutropenia
use
granulocyt
cutoff
result
ppv
chanc
includ
grade
neutropen
patient
addit
multinomi
classif
also
investig
binari
classif
singl
granulocyt
count
boundari
abil
correctli
distinguish
result
cellsl
neutropenia
cellsl
assess
use
variou
cut
point
maximis
product
sensit
specif
result
threshold
cellsl
excel
discriminatori
perform
tabl
patient
neutrophil
count
cellsl
miss
use
select
criterion
achiev
sensit
threshold
could
use
miss
patient
anc
accompani
decreas
specif
ppv
mistakenli
includ
patient
anc
cellsl
use
granulocyt
count
threshold
cellsl
result
specif
mistakenli
includ
patient
anc
cellsl
predict
normalgrad
neutropenia
sever
neutropen
sensit
ppv
neg
predict
valu
npv
separ
result
base
differ
grade
boundari
also
investig
tabl
use
product
sensit
specif
captur
grade
neutropenia
result
cellsl
achiev
use
granulocyt
count
cellsl
provid
sensit
specif
ppv
npv
grade
neutropenia
result
discrimin
use
threshold
give
sensit
specif
ppv
npv
exclus
patient
eosinophilia
cellsl
basophilia
cellsl
dataset
n
improv
correl
granulocyt
neutrophil
result
result
neutropen
patient
agreement
analysi
result
agreement
mean
differ
upper
limit
agreement
mean
differ
upper
limit
dataset
restrict
includ
patient
receiv
cytotox
chemotherapi
within
day
n
correl
improv
neutropenia
patient
respect
furthermor
blandaltman
plot
show
agreement
mean
differ
upper
limit
agreement
upper
limit
respect
good
correl
granulocyt
neutrophil
count
observ
linear
regress
line
almost
ident
line
ident
maintain
even
neutrophil
count
reduc
less
cellsl
refer
rang
relev
decis
point
oncolog
practic
blandaltman
analysi
indic
good
agreement
granulocyt
neutrophil
count
granulocyt
within
cellsl
neutrophil
count
neutrophil
count
less
cellsl
furthermor
present
first
definit
granulocyt
count
equival
ctcae
neutropen
grade
clinic
practic
would
littl
need
chang
manag
decis
base
specif
grade
neutropenia
like
side
specifi
threshold
patient
neutrophil
count
fall
therefor
investig
boundari
clinic
relev
threshold
identifi
cellsl
neutrophil
use
best
perform
granulocyt
count
would
cellsl
neutrophil
use
best
perform
granulocyt
count
would
cellsl
scenario
npv
translat
result
would
misclassifi
threshold
intern
guidelin
treatment
neutropen
fever
recommend
anc
cellsl
threshold
chang
clinic
manag
howev
note
guidelin
assum
full
clinic
assess
carri
threepart
differenti
analys
might
potenti
use
point
care
devic
patient
may
remot
clinician
therefor
work
analys
perform
granulocyt
refer
neutrophil
count
threshold
greater
allow
safeti
margin
requir
due
absent
clinic
inform
import
clinic
question
use
equival
granulocyt
count
indic
patient
anc
specifi
threshold
sure
correct
exampl
use
granulocyt
count
indic
neutrophil
result
less
best
perform
granulocyt
count
term
balanc
fals
neg
fals
posit
would
order
obtain
fals
neg
result
significantli
higher
threshold
need
use
would
offset
increas
fals
posit
clinic
decis
whether
accept
depend
upon
consequ
misclassif
result
howev
concept
would
test
appropri
clinic
trial
set
point
care
test
poct
system
differenti
measur
capabl
strength
data
larg
cohort
patient
employ
analysi
wide
varieti
patient
term
neoplasm
diagnosi
comorbid
demograph
inform
mani
possibl
neutrophil
abund
grade
neutropenia
repres
may
due
cytotox
treatment
chemotherapi
cancer
diagnosi
howev
find
must
interpret
consider
caution
number
limit
must
taken
account
draw
conclus
work
firstli
methodolog
granulocyt
extract
summat
differenti
direct
result
haematolog
analys
therefor
may
underestim
error
read
secondli
measur
made
stateofth
art
haematolog
analys
central
laboratori
albeit
part
routin
daili
practic
thirdli
recognis
differ
quantit
individu
white
cell
speci
use
differ
detect
technolog
mean
variat
count
technolog
due
cell
popul
differ
may
impact
result
eg
presenc
blast
immatur
granulocyt
neutrophil
suggest
technic
feasibl
use
granulocyt
alway
baselin
refer
analys
neutrophil
count
exclud
patient
high
risk
misclassif
wrong
side
specifi
decis
threshold
highrisk
patient
would
includ
eosinophilia
basophilia
activ
allerg
condit
studi
consid
singl
result
context
decis
make
possibl
measur
may
use
routin
monitor
conclud
larg
cohort
data
granulocyt
count
warrant
consider
surrog
indic
neutrophil
count
could
use
indic
ctcae
grade
neutropenia
use
could
consid
patient
suspect
febril
neutropenia
altern
neutrophil
count
may
readili
avail
howev
must
recognis
relationship
establish
measur
made
establish
laboratori
analys
system
relationship
assum
applic
laboratori
analys
employ
differ
detect
methodolog
poct
system
therefor
find
studi
extrapol
poct
situat
poct
use
threepart
differenti
white
count
consid
monitor
patient
chemotherapi
away
hospit
set
relationship
granulocyt
neutrophil
count
must
establish
use
technolog
use
routin
practic
appropri
cohort
patient
exhibit
rang
neutrophil
count
expect
experienc
precursor
clinic
trial
